Cardinal Health Inc SEC Filings

Cardinal Health (CAH) filed a Form 144 notifying the proposed sale of 42,870 common shares through Merrill (8890 Lyra Dr, Columbus, OH) on or about 08/19/2025. The filing reports an aggregate market value of $6,382,024.00 and shows 238,793,647 shares outstanding. The securities to be sold were acquired by the reporting person via performance stock vest (37,197 shares) and restricted stock vest (5,673 shares), with acquisition dates listed as 08/15/2025; a prior payment date of 02/15/2024 is noted for a portion of the holdings. No securities were reported sold by this person in the past three months. The filer certifies they are not aware of undisclosed material adverse information.

Cardinal Health (CAH) filed a Form 144 notifying a proposed sale of 143,606 common shares through Merrill on the NYSE, with an aggregate market value of $21,400,000 and an approximate sale date of 08/19/2025. The shares represent recently vested awards acquired on 08/15/2025 from Cardinal Health: 136,478 shares from performance stock vesting and 7,128 from restricted stock vesting. The filing reports 238,793,647 shares outstanding and indicates no securities sold by the filer in the past three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Cardinal Health insider filed a Form 144 to sell 25,151 shares of Common stock on or about 08/19/2025 with an aggregate market value of $4,192,926 and the shares are to be sold on the NYSE. The filing shows the securities were acquired through company grants that vested: one grant vested 06/30/2025 (5,322 shares) and two grants keyed to 08/15/2025 (5,285 restricted shares and 17,544 performance shares). The filer certifies no undisclosed material information.

Note: the filing tables list acquisition rows that sum to 28,151 shares while the notice states 25,151 shares to be sold, which is an inconsistency present in the document.

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 38,078 common shares through Merrill Lynch on the NYSE with an aggregate market value of $5,666,934.00, and approximately 238,793,647 shares outstanding. The securities to be sold were acquired mostly through performance unit vesting and restricted stock vesting on dates between November 15, 2022 and August 15, 2025, with specific lots of 18,500; 5,160; 5,300; 4,955; and 4,163 shares listed. The filer certifies no undisclosed material adverse information and provides a notice date and signature block as required by Rule 144.

Form 144 notice from Cardinal Health, Inc. (CAH) discloses a proposed sale of 41,575 common shares through Merrill Lynch on the NYSE with an aggregate market value reported as $6,186,923 and an approximate sale date of 08/19/2025. The securities being offered were acquired by the selling person through vesting events: performance stock vesting (30,077 shares on 08/15/2025 and 3,692 shares on 06/30/2025) and restricted stock vesting (7,806 shares on 08/15/2025). The filer certifies no undisclosed material adverse information and indicates no sales by the person in the past three months.

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 5,373 common shares through The Charles Schwab Corporation on the NYSE with an aggregate market value of $795,204.00. The filer acquired the shares as restricted stock units on 08/16/2024 (3,050 shares) and 02/15/2025 (2,323 shares). The filing states there were 238,793,647 shares outstanding and lists the approximate sale date as 08/19/2025. No securities were reported sold by the filer in the past three months, and no gifts or noncash payments are indicated.

Cardinal Health Form 144 notice: The filing reports a proposed sale of 13,500 shares of common stock through Merrill (Columbus, OH) with an aggregate market value of $2,009,030NYSE and total shares outstanding are reported as 238,793,647. The approximate sale date is 08/19/2025. The shares to be sold were acquired mostly on 08/15/2025 as restricted and performance stock vesting (3,863 restricted; 9,318 performance) and a smaller tranche on 02/15/2025 (319 restricted).

The filer certifies there are no undisclosed material adverse facts and notes no sales in the past three months. This is a routine insider sale notice required under Rule 144 describing the broker, quantity, acquisition dates and nature of acquisition.

Cardinal Health, Inc. announced the sale of $1.0 billion of senior notes: $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035, under an effective Form S-3ASR registration statement. The offering was made through an underwriting agreement dated August 13, 2025, with Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC serving as representatives of the underwriters. The disclosure references the registration statement number and notes that the cover page interactive data file is embedded in the Inline XBRL document. The Form 8-K is signed by Aaron E. Alt, Chief Financial Officer, and dated August 14, 2025.

Michelle D. Greene, Chief Information Officer of Cardinal Health, Inc. (CAH), filed a Form 4 reporting a securities transaction dated 08/12/2025. The filing lists transactions in common shares tied to performance share units, shows a reported quantity of 16,362 (marked with an "A") and another listed amount of 34,968 (marked with a "D"); the row shows a price of $0. The explanatory note states these are performance share units that will settle on August 15, 2025.

The form was signed by James E. Barnett, Attorney-in-fact on 08/12/2025. The filing identifies Greene's title and gives a reporting address in Dublin, Ohio. The document does not provide total outstanding shares or percent ownership, so materiality relative to the company-wide share count cannot be determined from this filing alone.